Literature DB >> 20816163

Core 3-derived O-glycans are essential for intestinal mucus barrier function.

Lijun Xia1.   

Abstract

O-Glycans are primary components of the intestinal mucins that form the mucus gel layer overlying the gut epithelium. Core 3-derived O-glycans, which are one of the major types of O-glycans, are primarily expressed in colon. To investigate the biological function of core 3-derived O-glycans, we engineered mice lacking core 3 beta1,3-N-acetylglucosaminyltransferase (C3GnT), an enzyme predicted to be important in synthesis of core 3-derived O-glycans. Disruption of the C3GnT gene eliminated core 3-derived O-glycans. C3GnT-deficient mice displayed a discrete, colon-specific reduction in Muc2 protein and increased permeability of the intestinal barrier. Moreover, these mice were highly susceptible to experimental triggers of colitis. These data reveal a requirement for core 3-derived O-glycans in colon mucus barrier function. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816163     DOI: 10.1016/S0076-6879(10)79007-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  11 in total

Review 1.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

2.  Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.

Authors:  Weijun Wang; Jinfang Zhao; Wenfang Gui; Dan Sun; Haijiang Dai; Li Xiao; Huikuan Chu; Fan Du; Qingjing Zhu; Bernd Schnabl; Kai Huang; Ling Yang; Xiaohua Hou
Journal:  Br J Pharmacol       Date:  2018-01-03       Impact factor: 8.739

3.  Highly Sensitive O-Glycan Profiling for Human Serum Proteins Reveals Gender-Dependent Changes in Colorectal Cancer Patients.

Authors:  Solomon T Gizaw; Stefan Gaunitz; Milos V Novotny
Journal:  Anal Chem       Date:  2019-04-24       Impact factor: 6.986

4.  γδ T-cell-deficient mice show alterations in mucin expression, glycosylation, and goblet cells but maintain an intact mucus layer.

Authors:  Olivia I Kober; David Ahl; Carmen Pin; Lena Holm; Simon R Carding; Nathalie Juge
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-02-06       Impact factor: 4.052

Review 5.  Mucin glycan foraging in the human gut microbiome.

Authors:  Louise E Tailford; Emmanuelle H Crost; Devon Kavanaugh; Nathalie Juge
Journal:  Front Genet       Date:  2015-03-19       Impact factor: 4.599

6.  Protein tyrosine phosphatase 1B deficiency ameliorates murine experimental colitis via the expansion of myeloid-derived suppressor cells.

Authors:  Jing Zhang; Bing Wang; Wen Zhang; Yao Wei; Zhen Bian; Chen-Yu Zhang; Limin Li; Ke Zen
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

7.  Polypeptide-GalNAc-T6 expression predicts better overall survival in patients with colon cancer.

Authors:  Luis Ubillos; Edgardo Berriel; Daniel Mazal; Sabina Victoria; Enrique Barrios; Eduardo Osinaga; Nora Berois
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

Review 8.  The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human.

Authors:  Anthony P Corfield
Journal:  Microorganisms       Date:  2018-08-02

Review 9.  Rotavirus Interactions With Host Intestinal Epithelial Cells.

Authors:  Joshua Oluoch Amimo; Sergei Alekseevich Raev; Juliet Chepngeno; Alfred Omwando Mainga; Yusheng Guo; Linda Saif; Anastasia N Vlasova
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

10.  Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancer.

Authors:  Srividya Venkitachalam; Leslie Revoredo; Vinay Varadan; Ryan E Fecteau; Lakshmeswari Ravi; James Lutterbaugh; Sanford D Markowitz; Joseph E Willis; Thomas A Gerken; Kishore Guda
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.